By quantifying the amount of tau in the brain tissue with PET imaging, physicians can appropriately stage Alzheimer's disease in patients and determine the best treatment options. "Identifying tau ...

In vivo imaging of tau pathology by PET will allow new insights into tau deposition in the human brain, facilitating research into causes, diagnosis and treatment of major neurodegenerative ...

One exam, a tau PET scan, relies on a radioactive tracer ... detect early stages of tau pathology and it requires specialized imaging centers. Other tests measure the level of amyloid beta ...

Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing ...

The biomarker findings also aligned with Braak NFT stages based on tau-PET imaging. This study demonstrates that pre-NFT tau assemblies in AD have distinct biochemical properties compared to those ...

Following this, the company has begun a multiple ascending dose (MAD) trial in patients with early Alzheimer's disease, with initial tau PET imaging data expected in the second half of 2026.

PET imaging is improved by employing edaravone to track oxidative stress, allowing for earlier detection of neurodegenerative ...

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's disease—in the brains of women over the age of 70 who took menopausal hormone ...

initial tau PET imaging data in Alzheimer’s patients expected H2 2026 - LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...